Linder, B.; Weirauch, U.; Ewe, A.; Uhmann, A.; Seifert, V.; Mittelbronn, M.; Harter, P.N.; Aigner, A.; Kögel, D.
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model. Cancers 2019, 11, 333.
https://doi.org/10.3390/cancers11030333
AMA Style
Linder B, Weirauch U, Ewe A, Uhmann A, Seifert V, Mittelbronn M, Harter PN, Aigner A, Kögel D.
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model. Cancers. 2019; 11(3):333.
https://doi.org/10.3390/cancers11030333
Chicago/Turabian Style
Linder, Benedikt, Ulrike Weirauch, Alexander Ewe, Anja Uhmann, Volker Seifert, Michel Mittelbronn, Patrick N. Harter, Achim Aigner, and Donat Kögel.
2019. "Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model" Cancers 11, no. 3: 333.
https://doi.org/10.3390/cancers11030333
APA Style
Linder, B., Weirauch, U., Ewe, A., Uhmann, A., Seifert, V., Mittelbronn, M., Harter, P. N., Aigner, A., & Kögel, D.
(2019). Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model. Cancers, 11(3), 333.
https://doi.org/10.3390/cancers11030333